0001971857-23-000356.txt : 20230703
0001971857-23-000356.hdr.sgml : 20230703
20230703141238
ACCESSION NUMBER: 0001971857-23-000356
CONFORMED SUBMISSION TYPE: 144
PUBLIC DOCUMENT COUNT: 1
FILED AS OF DATE: 20230703
DATE AS OF CHANGE: 20230703
SUBJECT COMPANY:
COMPANY DATA:
COMPANY CONFORMED NAME: ARS Pharmaceuticals, Inc.
CENTRAL INDEX KEY: 0001671858
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 811489190
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 144
SEC ACT: 1933 Act
SEC FILE NUMBER: 001-39756
FILM NUMBER: 231064715
BUSINESS ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
BUSINESS PHONE: 858-771-9307
MAIL ADDRESS:
STREET 1: 11682 EL CAMINO REAL, SUITE 120
CITY: SAN DIEGO
STATE: CA
ZIP: 92130
FORMER COMPANY:
FORMER CONFORMED NAME: Silverback Therapeutics, Inc.
DATE OF NAME CHANGE: 20160412
REPORTING-OWNER:
COMPANY DATA:
COMPANY CONFORMED NAME: Shawver Laura
CENTRAL INDEX KEY: 0001551891
FILING VALUES:
FORM TYPE: 144
MAIL ADDRESS:
STREET 1: 1255 CRESCENT GREEN DRIVE, SUITE 250
CITY: CARY
STATE: NC
ZIP: 27518
144
1
primary_doc.xml
144
0001551891
XXXXXXXX
LIVE
0001671858
ARS Pharmaceuticals, Inc.
001-39756
11682 EL CAMINO REAL, SUITE 120
SAN DIEGO
CA
92130
858-771-9307
Shawver Laura
Director
Common
Merrill Lynch
101 S. Ellsworth Ave., 4th Floor
San Mateo
CA
94401
100000
668450.00
94403028
07/03/2023
Nasdaq
Common
07/03/2023
Stock Award Option Exercise
ARS Pharmaceuticals, Inc.
N
26520
07/03/2023
Cash
Common
04/29/2020
Stock Option Award
ARS Pharmaceuticals, Inc.
N
73480
04/29/2020
Cash Upon Exercise
N
Laura Shawver
6638 Avenida De Las Pescas
La Jolla
CA
92037
Common
05/08/2023
57100
351917.52
Laura Shawver
6638 Avenida De Las Pescas
La Jolla
CA
92037
Common
05/09/2023
42900
227963.91
Laura Shawver
6638 Avenida De Las Pescas
La Jolla
CA
92037
Common
06/01/2023
73059
469858.26
Laura Shawver
6638 Avenida De Las Pescas
La Jolla
CA
92037
Common
06/02/2023
26941
187183.35
The nature of the payment will be cash for the stock Option award of 73,480 shares referenced in the Securities to be Sold section upon exercise
07/03/2023
08/15/2022
Laura Shawver